Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14:89–103.

CAS  PubMed  PubMed Central  Google Scholar 

Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y. Colorectal cancer: genetics of development and metastasis. J Gastroenterol. 2006;41:185–92.

Article  CAS  PubMed  Google Scholar 

Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020;158:291–302.

Article  CAS  PubMed  Google Scholar 

Padua D, Massagué J. Roles of TGFβ in metastasis. Cell Res. 2009;19:89–102.

Article  CAS  PubMed  Google Scholar 

Massagué J. TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012;13:616–30.

Article  PubMed  PubMed Central  Google Scholar 

Picon A, Gold LI, Wang J, Cohen A, Friedman E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Cancer Epidemiol Biomarkers Prev. 1998;7:497–504.

CAS  PubMed  Google Scholar 

Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, et al. Circulating transforming growth factor β1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res. 2001;7:1258–62.

CAS  PubMed  Google Scholar 

Seoane J, Gomis RR. TGF-β family signaling in tumor suppression and cancer progression. Cold Spring Harb Perspect Biol. 2017;9: a022277.

Article  PubMed  PubMed Central  Google Scholar 

Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, et al. TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst. 2014;106:djt369.

Sheen YY, Kim M-J, Park S-A, Park S-Y, Nam J-S. Targeting the transforming growth factor-β signaling in cancer therapy. Biomol Therap. 2013;21:323–31.

Article  CAS  Google Scholar 

Rivera GA, Wakelee H. Lung cancer in never smokers. adv exp med biol. 2016;893:43–57.

Article  PubMed  Google Scholar 

Hira SK, Rej A, Paladhi A, Singh R, Saha J, Mondal I, et al. Galunisertib drives Treg fragility and promotes dendritic cell-mediated immunity against experimental lymphoma. iScience [Internet]. 2020 [cited 2022 Sep 10];23. Available from: https://www.cell.com/iscience/abstract/S2589-0042(20)30815-4

Shi Y, Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.

Article  CAS  PubMed  Google Scholar 

Xu X, Zheng L, Yuan Q, Zhen G, Crane JL, Zhou X, et al. Transforming growth factor-β in stem cells and tissue homeostasis. Bone Res. 2018;6:1–31.

Article  Google Scholar 

Hinck AP, Mueller TD, Springer TA. Structural biology and evolution of the TGF-β family. Cold Spring Harb Perspect Biol. 2016;8: a022103.

Article  PubMed  PubMed Central  Google Scholar 

Huang T, Schor S, Hinck A. Biological activity differences between TGF-β1 and TGF-β3 correlate with differences in the rigidity and arrangement of their component monomers. Biochemistry. 2014;53:5737–5749.

Xu P, Lin X, Feng X-H. Posttranslational regulation of Smads. Cold Spring Harb Perspect Biol. 2016;8: a022087.

Article  PubMed  PubMed Central  Google Scholar 

Xu L. Regulation of Smad activities. Biochim Biophys Acta. 2006;1759:503–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miyazawa K, Miyazono K. Regulation of TGF-β family signaling by inhibitory Smads. Cold Spring Harb Perspect Biol. 2017;9: a022095.

Article  PubMed  PubMed Central  Google Scholar 

Zhang YE. Non-Smad signaling pathways of the TGF-β family. Cold Spring Harb Perspect Biol. 2017;9: a022129.

Article  PubMed  PubMed Central  Google Scholar 

Hartsough MT, Mulder KM. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem. 1995;270:7117–24.

Article  CAS  PubMed  Google Scholar 

Mulder KM, Morris SL. Activation of p21ras by transforming growth factor beta in epithelial cells. J Biol Chem. 1992;267:5029–31.

Article  CAS  PubMed  Google Scholar 

Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21:144.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian M, Schiemann WP. The TGF-β paradox in human cancer: an update. Future Oncol. 2009;5:259–71.

Article  CAS  PubMed  Google Scholar 

Haque S, Morris JC. Transforming growth factor-β: a therapeutic target for cancer. Hum Vaccin Immunother. 2017;13:1741–50.

Article  PubMed  PubMed Central  Google Scholar 

Lavarone A, Massagué J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature. 1997;387:417–22.

Article  Google Scholar 

Lasorella A, Noseda M, Beyna M, Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 2000;407:592–8.

Article  CAS  PubMed  Google Scholar 

Shen L, Qu X, Ma Y, Zheng J, Chu D, Liu B, et al. Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer. Oncogenesis. 2014;3:e86–e86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramesh S, Wildey GM, Howe PH. Transforming growth factor β (TGFβ)-induced apoptosis. Cell Cycle. 2009;8:11–7.

Article  CAS  PubMed  Google Scholar 

Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318–29.

Article  PubMed  Google Scholar 

Villalba M, Evans SR, Vidal-Vanaclocha F, Calvo A. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy. Cell Tissue Res. 2017;370:29–39.

Article  CAS  PubMed  Google Scholar 

Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. JCO. 2005;23:2078–93.

Article  CAS  Google Scholar 

McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology. Nat Immunol. 2007;8:1390–7.

Article  CAS  PubMed  Google Scholar 

Perez LG, Kempski J, McGee HM, Pelzcar P, Agalioti T, Giannou A, et al. TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer. Nat Commun. 2020;11:2608.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung B, Staudacher JJ, Beauchamp D. Transforming growth factor β superfamily signaling in development of colorectal cancer. Gastroenterology. 2017;152:36–52.

Article  CAS  PubMed  Google Scholar 

Nguyen HT, Duong H-Q. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy. Oncol Lett. 2018;16:9–18.

PubMed  PubMed Central  Google Scholar 

Razzaque MS, Atfi A. TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma. Comput Struct Biotechnol J. 2020;18:2568–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Najjar Sadeghi R, Saeedi N, Sahba N, Sadeghi A. SMAD4 mutations identified in Iranian patients with colorectal cancer and polyp. Gastroenterol Hepatol Bed Bench. 2021;14:S32–40.

Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 2014;16:488–94.

Article  CAS  PubMed  Google Scholar 

Nieto MA, Huang RY-J, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21–45.

Hu Y, Dai M, Zheng Y, Wu J, Yu B, Zhang H, et al. Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer. Clin Epigenet. 2018;10:154.

Article  CAS  Google Scholar 

David CJ, Huang Y-H, Chen M, Su J, Zou Y, Bardeesy N, et al. TGF-β tumor suppression through a lethal EMT. Cell. 2016;164:1015–30.

Article  CAS  PubMed  PubMed Central